Assignee profile:

Theralase Technologies, Inc.

City:

Toronto

Country:

Canada

Published Applications:

9

Last publication date:

2022-09-22

Patent Grants:

9

Last grant date:

2023-11-14

Top Inventors for applications by Theralase Technologies, Inc.

These are the the leading inventors for applications assigned to Theralase Technologies, Inc.:

Recent patent applications by Theralase Technologies, Inc.

Theralase Technologies, Inc. based in Toronto, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-09-22 ✅ Patent 11,813,330 granted on 2023-11-14
US20220296709A1
Human necessities

Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agents

#2 | 2022-03-03 ✅ Patent 12,311,190 granted on 2025-05-27
US20220062654A1
Human necessities

Apparatus and method for irradiating inside an object

#3 | 2020-07-16 ✅ Patent 11,464,798 granted on 2022-10-11
US20200222450A1
Human necessities

Vaccine containing cancer cells inactivated by photodynamic treatment with metal-based coordination complexes, and immunotherapy method using same

#4 | 2019-09-26 ✅ Patent 11,793,818 granted on 2023-10-24
US20190290657A1
Human necessities

Method for treating conditions associated with hyperproliferating cells comprising combined administration of a cannabinoid receptor agonist and radiation therapy

#5 | 2017-10-26 ✅ Patent 10,335,608 granted on 2019-07-02
US20170304648A1
Human necessities

Photodynamic compounds and methods for activating them using ionizing radiation and/or other electromagnetic radiation for therapy and/or diagnostics

#6 | 2017-04-13 ✅ Patent 11,241,587 granted on 2022-02-08
US20170100606A1
Human necessities

Fiber optic light delivery, monitoring and apparatus therefor

#7 | 2017-02-16 ✅ Patent 10,525,279 granted on 2020-01-07
US20170043179A1
Human necessities

Apparatus and method for multiwavelength photodynamic therapy

#8 | 2017-02-16 ✅ Patent 10,111,936 granted on 2018-10-30
US20170042976A1
Human necessities

Metal-glycoprotein complexes and photodynamic therapy of immune privileged sites with same

#9 | 2016-07-21 ✅ Patent 9,737,565 granted on 2017-08-22
US20160206653A1
Human necessities

Metal-glycoprotein complexes and their use as chemotherapeutic compounds

Also check out Theralase Technologies, Inc.'s (Toronto, Canada) applicant profile with 9 patent applications submitted.

AssigneeID:

371741 ⎘